Inpatient cervical ripening with Dilapan-S®
may drive changes in care pathways that improve resource utilization and reduce costs of care.1

Childbirth is a common, resource-intensive reason for a hospital stay

Childbirth is the most common reason for an inpatient stay in the United States and is associated with substantial resource use.2-4

More than 1 in 4 deliveries in the US are induced5

Up to 85% of induced labors require cervical ripening6

Improvements in the labor care pathway could have considerable implications on hospital resources and healthcare finances

When units are short-staffed, saving time in the care pathway is extremely valuable

Nursing divisions were short-staffed for decades before the COVID-19 pandemic amplified the problem.7,8

Staffing shortages represent a considerable risk to patient safety, including higher rates of severe maternal complications.9,10

58% of OB/GYN clinicians rank nursing shortages as the top risk to patient safety in labor and delivery.10*

*Results from a survey of 1,130 obstetrics and gynecology clinicians in the 2021 Future of Obstetrics Industry Survey Report conducted by the Ob Hospitalist™ Group.10

Pharmacologic agents for cervical ripening are time-intensive for nurses
Synthetic prostaglandins require extensive fetal monitoring, and many are frequently readministered.11

With Dilapan-S®, lower-acuity care may be possible, impacting:



“The ideal ripening agent or procedure should be simple to use, noninvasive, and effective within a reasonable amount of time; it should not stimulate or induce labor during the ripening process or increase maternal, fetal, or neonatal morbidity.”11

—Association of Women’s Health, Obstetric and Neonatal Nurses, 2020

Dilapan-S® may allow for patients who are not considered high-risk to be cared for in a lower-acuity setting during cervical ripening1

No additional fetal monitoring requirement unlike synthetic prostaglandins.12-15

In situ for up to 24 hours without need for additional monitoring12

Limited safety concerns relative to synthetic prostaglandins12,16

In comparison to a fully equipped labor and delivery room, lower-acuity options for cervical ripening with Dilapan-S® could be1:

  • Sharing a fetal monitor between rooms equipped for initial assessments and insertion of Dilapan-S®
  • A lounge where pregnant patients can remain mobile during cervical ripening with resting, eating, and drinking facilities
  • Simple hospital patient rooms without fetal-monitoring facilities

Find out how Dilapan-S® can help optimize hospital resource efficiency

Download information about Dilapan-S®


Learn about Dilapan-S® proper use and multiple modes of action.

Discover resources to help you get started with Dilapan-S® in your practice